NX-13

Vendor: Abmole

Type: Molecular

SKU: M45116

Explore specifications & documents
$506.00 USD
Shipping calculated at checkout.

Documents

Coa

Available in stock (500)

Request a quotation
  • Customs clearance fees may apply
  • Worldwide shipping available.
For research use only — not intended for clinical or diagnostic purposes.
NX-13

NX-13

$506.00 USD

THE SCIENCE, IN DETAIL

Know your product.

Specifications
Bioactivity
NX-13 is a novel oral small molecule NLRX1 agonist, which can increase oxidative phosphorylation in immune cells, decrease the differentiation of effector CD4+ T cells, and reduce the production of inflammatory cytokines in the gastrointestinal tract through activation of the NLRX1 pathway, and can be used in studies related to ulcerative colitis (UC).
Casnumber
2389235-01-0
Formula
C24H21N3O3
Mw
399.44
Psmiles
CC1=NC(=CC=C1)OC2=CC(=CC(=C2)OC3=CC=CC(=N3)C)OC4=CC=CC(=N4)C
Purity
>98.0%
Solubility
DMSO >100 mg/mL
Target synonyms
Amelenodor
Technical documents

Documents

Coa

A PARTNER IN YOUR RESEARCH

More time for discovery. Less time sourcing.

Bring your laboratory requirements together with scientific advice, global sourcing and dedicated procurement support.

Explore our services

Starting a new laboratory?

Plan your laboratory with our New-Lab programme.

Discover New-Lab